| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0acc7fd312a68983fb8b9d120043467e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 |
| filingDate |
2018-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_490a517aced349cd633154f4503a849f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64411111af4ddd1983b7743f6293aa86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a1bc4c09f067e00a66e8001b014809e |
| publicationDate |
2020-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020038348-A1 |
| titleOfInvention |
Methods and materials for reducing scar formation during wound healing |
| abstract |
This document provides methods and materials for reducing scar formation (e.g., scar formation during wound healing) and/or for reducing keloid formation (e.g., keloid formation that occurs during wound healing or keloid formation that does not occur during wound healing). For example, methods and materials for topically administering pentamidine to reduce scar formation and/or to reduce keloid formation are provided. |
| priorityDate |
2017-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |